NATICK, Mass., June 20, 2011 /PRNewswire/ — Boston Scientific
Corporation (NYSE:
BSX) today announced the global launch of its Mustang™
PTA Balloon Catheter, a highly deliverable 0.035 inch percutaneous
transluminal angioplasty (PTA) catheter designed for a wide range
of peripheral angioplasty procedures.  The Company plans to
launch the product immediately in the U.S., Europe and other
international markets.

Boston Scientific developed the Mustang PTA Balloon Catheter to
meet physician needs for a low-profile, high-pressure balloon
catheter in a wide range of sizes.  It is the first to use
Boston Scientific’s NyBax™ Balloon Material, a proprietary
co-extrusion of nylon and Pebax® polymers engineered to provide
high-pressure, non-compliant dilatation in a low-profile balloon.
 The Mustang Balloon Catheter offers excellent rated burst
pressure (up to 24 atmospheres) and is the only 7 x 200 mm balloon
compatible with a 5 French introducer sheath.  Available in
203 sizes, it provides the broadest matrix of any available
peripheral balloon.  

“The Mustang Balloon Catheter offers a low tip profile and
excellent deliverability to accommodate workhorse and complex
lesions,” said Joe Fitzgerald, Senior Vice President and President
of Boston Scientific’s Endovascular Unit.  “Its versatility
and extensive size matrix allow physicians to address nearly every
peripheral need, ranging from treating blockages in femoral
arteries to dialysis fistulae.  The Mustang Balloon Catheter
demonstrates Boston Scientific’s commitment to continuing its
legacy as a pioneer and global leader in peripheral balloon
angioplasty.”

An estimated 8 to 10 million patients in the United States alone
suffer from peripheral artery disease (PAD), which is characterized
by blockages in vessels of the peripheral vasculature and is
associated with high

‘/>”/>

SOURCE